About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Pdgfbtm2Cbet
targeted mutation 2, Christer Betsholtz
MGI:2385913
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Pdgfbtm1Cbet/Pdgfbtm2Cbet
Tg(Tie1-cre)9Ref/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA MGI:2449991


Genotype
MGI:2449991
cn1
Allelic
Composition
Pdgfbtm1Cbet/Pdgfbtm2Cbet
Tg(Tie1-cre)9Ref/0
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdgfbtm1Cbet mutation (0 available); any Pdgfb mutation (15 available)
Pdgfbtm2Cbet mutation (1 available); any Pdgfb mutation (15 available)
Tg(Tie1-cre)9Ref mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• thin myocardium is seen at E18.5, however this abnormality is normalized by 1 month of age

cardiovascular system
• E15.5 embryos show irregular capillary diameter with microaneurysms in the brain
• capillaries in the striatum with associated pericytes are straighter and more uniform in diameter
• in the cerebellum, see a reduction of capillary density in the gray matter and the presence of numerous enlarged capillaries
• in the striatum, capillary density is lower, but numerous tortuous capillaries with increased diameter are seen in capillary regions not associated with pericytes
• in the cerebellum, see a reduction of capillary density in the gray matter and the presence of numerous enlarged capillaries
• E18.5 glomeruli show dilation of the remaining capillary loops
• 3-week old mutants show an increase in the diameter of individual capillary loops
• in the striatum, capillary density is lower, but numerous tortuous capillaries with increased diameter are seen in capillary regions not associated with pericytes
• microaneurysm formation in the brain
• in mutants with greater than 50% of normal overall CNS pericyte density, the retinal vasculature displays irregular microvessel diameter, microaneurysms, and increased vascular regression
• in mutants with less than 50% of normal pericyte density, the retinas develop regions with massive increase of abnormal vessels extending into the vitreous and choroid
• exhibit a variable reduction in pericyte density in CNS vessels, affecting arteries, veins and capillaries (J:78544)
• retinas in mutants with the lowest overall CNS pericyte density however display focal regions of increased pericyte density (J:78544)
• exhibit a significant reduction in pericyte density in E15.5 embryos that persists into adulthood (J:89186)
• placental defects at E18.5 include dilation of both fetal and maternal vessels due to a reduction in the number of pericytes and trophoblasts
• thin myocardium is seen at E18.5, however this abnormality is normalized by 1 month of age
• show scattered small hemorrhages deep in the cerebral parenchyma; bleeding seems to start from capillary branching points

vision/eye
• mutants with less than 52% of the normal pericyte density in the cerebellum show typical hallmarks of proliferative retinopathy, affecting at least one eye
• retinas of mutants with the lowest overall CNS pericyte density are contracted and often attached to the retinal pigment epithelial cells and the lens
• in mutants with greater than 50% of normal overall CNS pericyte density, the retinal vasculature displays irregular microvessel diameter, microaneurysms, and increased vascular regression
• in mutants with less than 50% of normal pericyte density, the retinas develop regions with massive increase of abnormal vessels extending into the vitreous and choroid
• regions with high pericyte density show loss of organization of the neural layers and folding of the photoreceptor layer producing typical photoreceptor rosette profiles

embryo
• placental defects at E18.5 include dilation of both fetal and maternal vessels due to a reduction in the number of pericytes and trophoblasts

homeostasis/metabolism
• mutants older than 12 months develop mild but significant increases in albumin content in urine

nervous system
• microaneurysm formation in the brain
• show scattered small hemorrhages deep in the cerebral parenchyma; bleeding seems to start from capillary branching points
• postnatal brains show increased density of microglial cells at sites of bleeding
• postnatal brains show increased density of microglial cells and upregulated expression of glial fibrillary acidic protein at sites of bleeding, hallmarks of reactive gliosis

renal/urinary system
• mutants older than 12 months develop mild but significant increases in albumin content in urine
• E18.5 glomeruli show a reduction in tuft complexity and dilation of the remaining capillary loops
• 3-week old mutants show glomerular dilation, both an increased glomerulus diameter and an increase in the diameter of the individual capillary loops, however by 6 and 21 months of age, no signs of increased glomerular pathology are seen
• E18.5 glomeruli show dilation of the remaining capillary loops
• 3-week old mutants show an increase in the diameter of individual capillary loops
• most glomeruli show a reduced mesangial core, although some completely lack mesangial cells at E18.5
• the mesangial deficiency is largely corrected at 3 weeks of age

hematopoietic system
• postnatal brains show increased density of microglial cells at sites of bleeding

immune system
• postnatal brains show increased density of microglial cells at sites of bleeding

cellular
• most glomeruli show a reduced mesangial core, although some completely lack mesangial cells at E18.5
• the mesangial deficiency is largely corrected at 3 weeks of age





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/05/2024
MGI 6.24
The Jackson Laboratory